Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Yale University grants Biohaven exclusive IP rights

Executive Summary

Yale University granted Biohaven Pharmaceuticals Holding Co. Ltd. an exclusive license to its intellectual property surrounding the use of glutamate-modulating agents, including riluzole, which the company will use in its development of therapeutics for neuropsychiatric conditions, including treatment-resistant mood and anxiety disorders.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R+D and Marketing-Licensing
    • Includes Equity
    • Includes Royalty or Profit Split Information

Related Companies

Advertisement
UsernamePublicRestriction

Register